Exhibitors Search
RECEPTECH, Inc.
| Exhibition | PARTNERING |
|---|---|
| Booth no. | A60 |
| Country | Korea, South |
| Address | 82 Baegot 2-ro, Siheung-si, Gyeonggi-do, Republic of Korea |
| Tel (Rep.) | 010-9425-4723 |
| Website | http://receptech.com |
Company Introduction
RecepTech Inc.'s core technology is to develop products that can be applied to various fields through the technology to mass-produce and purify various receptors in E. coli system and the technology to manufacture them into nanodisc.
The core technology is a technology for producing cancer cell-specific G-protein-coupled receptors in the form of nanodisc, which are the optimal antigens, and a targeted anticancer antibody screening system that resolves nonspecific antibody background through this technology. A domestic patent has been registered and a U.S. application has been filed.
The core technology is a technology for producing cancer cell-specific G-protein-coupled receptors in the form of nanodisc, which are the optimal antigens, and a targeted anticancer antibody screening system that resolves nonspecific antibody background through this technology. A domestic patent has been registered and a U.S. application has been filed.
Promotional video
Exhibit Item
A Targeted Anticancer Antibody Screening Platform Based on Cancer Cell-specific GPCR (G-protein-coupled receptor) Nanodisc Antigen
Exhibit Item Images
-
Product Name : A Targeted Anticancer Antibody Screening Platform Based on Cancer Cell-specific GPCR (G-protein-coupled receptor) Nanodisc AntigenProducts using this technology are cancer cell-targeting antibody and small molecule screening system using cancer cell-specific (G-protein-coupled receptor) nanodisc antigen. which can accurately and quickly discover various cancer cell-targeting anticancer antibody and small molecule candidates.
Exhibit Description
Products using this technology are cancer cell-targeting antibody and small molecule screening system using cancer cell-specific (G-protein-coupled receptor) nanodisc antigen. which can accurately and quickly discover various cancer cell-targeting anticancer antibody and small molecule candidates.
Co-Exhibitor or Partner’s Information
| Company Name | Country |
|---|---|
KYUNGYON EXHIBITION CORP.